lactic acid has been researched along with End Stage Liver Disease in 18 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
End Stage Liver Disease: Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
| Excerpt | Relevance | Reference |
|---|---|---|
| "2,584 septic shock patients were enrolled." | 1.56 | Presentation and outcomes of end stage liver disease patients presenting with septic shock to the emergency department. ( Heffner, AC; Okonkwo, E; Rozario, N, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 13 (72.22) | 2.80 |
| Authors | Studies |
|---|---|
| Mani, I | 1 |
| Alexopoulos, T | 1 |
| Hadziyannis, E | 1 |
| Tsiriga, A | 1 |
| Vourli, G | 1 |
| Alexopoulou, A | 1 |
| Chen, XF | 1 |
| Li, X | 1 |
| Gong, M | 1 |
| Fu, S | 1 |
| Zhang, J | 1 |
| Wu, S | 1 |
| Horvatits, T | 1 |
| Mahmud, N | 3 |
| Serper, M | 2 |
| Seiz, O | 1 |
| Reher, D | 1 |
| Drolz, A | 1 |
| Sarnast, N | 1 |
| Gu, W | 1 |
| Erasmus, HP | 1 |
| Allo, G | 1 |
| Ferstl, P | 1 |
| Wittmann, S | 1 |
| Piecha, F | 1 |
| Groth, S | 1 |
| Zeuzem, S | 1 |
| Schramm, C | 1 |
| Huber, S | 1 |
| Rösch, T | 1 |
| Lohse, AW | 1 |
| Trebicka, J | 1 |
| Ogola, G | 1 |
| Asrani, SK | 5 |
| Kluwe, J | 1 |
| Chandnani, S | 1 |
| Rathi, P | 1 |
| Udgirkar, SS | 1 |
| Sonthalia, N | 1 |
| Contractor, Q | 1 |
| Jain, S | 1 |
| Okonkwo, E | 1 |
| Rozario, N | 1 |
| Heffner, AC | 1 |
| Sarmast, N | 2 |
| Ogola, GO | 2 |
| Kouznetsova, M | 1 |
| Leise, MD | 1 |
| Bahirwani, R | 1 |
| Maiwall, R | 1 |
| Tapper, E | 1 |
| Trotter, J | 1 |
| Bajaj, JS | 1 |
| Thacker, LR | 1 |
| Tandon, P | 1 |
| Wong, F | 1 |
| Reddy, KR | 1 |
| O'Leary, JG | 1 |
| Masica, A | 1 |
| Modrykamien, AM | 1 |
| Kamath, PS | 2 |
| Singh, S | 1 |
| Verma, N | 1 |
| Singh, V | 1 |
| Kaplan, DE | 1 |
| Taddei, TH | 1 |
| Bhakta, D | 1 |
| Patel, M | 1 |
| Ma, TW | 1 |
| Boutté, J | 1 |
| Rezar, R | 1 |
| Lichtenauer, M | 1 |
| Schwaiger, P | 1 |
| Seelmaier, C | 1 |
| Pretsch, I | 1 |
| Ausserwinkler, M | 1 |
| Reichle, J | 1 |
| Jirak, P | 1 |
| Jung, C | 1 |
| Strohmer, B | 1 |
| Hoppe, UC | 1 |
| Wernly, B | 1 |
| Walter, A | 1 |
| Rudler, M | 1 |
| Olivas, P | 1 |
| Moga, L | 1 |
| Trépo, E | 1 |
| Robic, MA | 1 |
| Ollivier-Hourmand, I | 1 |
| Baiges, A | 1 |
| Sutter, O | 1 |
| Bouzbib, C | 1 |
| Peron, JM | 1 |
| Le Pennec, V | 1 |
| Ganne-Carrié, N | 1 |
| Garcia-Pagán, JC | 1 |
| Mallet, M | 1 |
| Larrue, H | 1 |
| Dao, T | 1 |
| Thabut, D | 1 |
| Hernández-Gea, V | 1 |
| Nault, JC | 1 |
| Bureau, C | 1 |
| Allaire, M | 1 |
| Agarwal, A | 1 |
| Sharma, S | 1 |
| Saraya, A | 1 |
| Cardoso, NM | 1 |
| Silva, T | 2 |
| Basile-Filho, A | 3 |
| Mente, ED | 2 |
| Castro-e-Silva, O | 1 |
| Nicolini, EA | 1 |
| Auxiliadora-Martins, M | 1 |
| Silva, Ode C | 1 |
| Wu, JF | 1 |
| Wu, RY | 1 |
| Chen, J | 1 |
| Ou-Yang, B | 1 |
| Chen, MY | 1 |
| Guan, XD | 1 |
| Cardoso, N | 1 |
| Cagnolati, D | 1 |
| Freitas, T | 1 |
| Castro e Silva, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Blood Lactate Level in Prediction of Outcome of Cirrhotic Patients at The Intensive Care Unit[NCT06121908] | 50 participants (Anticipated) | Observational | 2023-11-15 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 other studies available for lactic acid and End Stage Liver Disease
| Article | Year |
|---|---|
An exploratory study of ascitic fluid lactate as prognostic factor of mortality in cirrhotic patients with spontaneous bacterial peritonitis.
Topics: Acute-On-Chronic Liver Failure; Ascitic Fluid; End Stage Liver Disease; Humans; Lactic Acid; Liver C | 2021 |
Prognostic Role of MELD-Lactate in Cirrhotic Patients' Short- and Long-Term Prognosis, Stratified by Causes of Cirrhosis.
Topics: Critical Illness; End Stage Liver Disease; Humans; Lactic Acid; Liver Cirrhosis; Prognosis; Retrospe | 2022 |
Establishment of MELD-lactate clearance scoring system in predicting death risk of critically ill cirrhotic patients.
Topics: Critical Illness; End Stage Liver Disease; Humans; Lactic Acid; Liver Cirrhosis; Prognosis; Retrospe | 2022 |
MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis.
Topics: End Stage Liver Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lactic | 2023 |
CLINICAL UTILITY OF RISK SCORES IN VARICEAL BLEEDING.
Topics: Adult; Blood Transfusion; End Stage Liver Disease; Endoscopy; Esophageal and Gastric Varices; Female | 2019 |
Presentation and outcomes of end stage liver disease patients presenting with septic shock to the emergency department.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; APACHE; Body Temp | 2020 |
Model for End-Stage Liver Disease-Lactate and Prediction of Inpatient Mortality in Patients With Chronic Liver Disease.
Topics: Aged; Clinical Decision-Making; Decision Support Techniques; End Stage Liver Disease; Female; Hospit | 2020 |
Reply.
Topics: End Stage Liver Disease; Humans; Inpatients; Lactic Acid; Severity of Illness Index | 2020 |
Letter to the Editor: MELD-Lactate-the New Kid on the Block.
Topics: End Stage Liver Disease; Humans; Inpatients; Lactic Acid; Liver Diseases; Severity of Illness Index | 2020 |
The Predictive Role of Model for End-Stage Liver Disease-Lactate and Lactate Clearance for In-Hospital Mortality Among a National Cirrhosis Cohort.
Topics: Cohort Studies; End Stage Liver Disease; Hospital Mortality; Humans; Lactic Acid; Liver Cirrhosis; L | 2021 |
Model for End-Stage Liver Disease Lactate Score and Prediction of Inpatient Mortality in Critically Ill Patients With Cirrhosis.
Topics: Critical Illness; End Stage Liver Disease; Humans; Inpatients; Intensive Care Units; Lactic Acid; Li | 2021 |
Thinking fast and slow: lactate and MELD-XI (model for end-stage liver disease excluding INR) are useful for estimating mortality after cardiopulmonary resuscitation.
Topics: Cardiopulmonary Resuscitation; End Stage Liver Disease; Humans; International Normalized Ratio; Lact | 2021 |
Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
Topics: Biomarkers; End Stage Liver Disease; Esophageal and Gastric Varices; Female; France; Gastrointestina | 2021 |
Letter to the Editor: Defining the Futility for Rescue Transjugular Intrahepatic Portosystemic Shunt Using the Model for End-Stage Liver Disease Score and Lactate in Variceal Bleed.
Topics: End Stage Liver Disease; Esophageal and Gastric Varices; Humans; Lactic Acid; Medical Futility; Port | 2021 |
A new formula as a predictive score of post-liver transplantation outcome: postoperative MELD-lactate.
Topics: Adult; End Stage Liver Disease; Female; Humans; Lactic Acid; Liver Transplantation; Male; Middle Age | 2014 |
The use of perioperative serial blood lactate levels, the APACHE II and the postoperative MELD as predictors of early mortality after liver transplantation.
Topics: APACHE; Bilirubin; Biomarkers; Creatinine; End Stage Liver Disease; Female; Humans; International No | 2011 |
Early lactate clearance as a reliable predictor of initial poor graft function after orthotopic liver transplantation.
Topics: Adult; Aged; Biomarkers; End Stage Liver Disease; Female; Follow-Up Studies; Graft Rejection; Graft | 2011 |
Can joint analysis of postoperative MELD, base excess and blood lactate levels be used as an index of postoperative outcome for patients submitted to liver transplantation?
Topics: Adult; Alanine Transaminase; Biomarkers; End Stage Liver Disease; Female; Humans; Ischemia; Lactic A | 2013 |